{{Rsnum
|rsid=1152746
|Chromosome=1
|position=192827775
|Orientation=minus
|GMAF=0.2351
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 47.3 | 47.3 | 5.4
| HCB | 68.6 | 28.5 | 2.9
| JPT | 73.5 | 23.0 | 3.5
| YRI | 45.6 | 46.3 | 8.2
| ASW | 65.5 | 27.3 | 7.3
| CHB | 68.6 | 28.5 | 2.9
| CHD | 78.7 | 21.3 | 0.0
| GIH | 63.4 | 31.7 | 5.0
| LWK | 57.8 | 33.9 | 8.3
| MEX | 52.6 | 42.1 | 5.3
| MKK | 64.7 | 32.0 | 3.3
| TSI | 66.3 | 30.7 | 3.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=18347610
|Title=Further evidence for association of the [[RGS2]] gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region
}}

{{PMID Auto
|PMID=22615781
|Title=Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}